|
|
|
| Research Progress of in Vitro Diagnostic Technologies for SARS-CoV-2 |
FAN Yue-lei,WANG Yue,WANG Heng-zhe,LI Dan-dan,MAO Kai-yun( ) |
| Shanghai Information Center for Life Sciences, Shanghai Institute of Nutrition and Health,Chinese Academy of Sciences, Shanghai 200031,China |
|
|
|
Abstract With the intensification of coronavirus pandemic, the research and development of in vitro diagnostic technologies and products for SARS-CoV-2 attracts great attention in the global biomedical field. The research and development of in vitro diagnostic technologies and products is of great importance in enhancing the ability to prevent and control emerging infectious diseases. The global research status and future trend of SARS-CoV-2 diagnostic technologies and products was reviewed,including not only the traditional molecular diagnostic and immunodiagnostic technologies, but also the application of new technologies, such as CRISPR technology, biosensor technology, nanotechnology, in SARS-CoV-2 testing, and the research and development strategy and technical characteristics were also analyzed in order to provide a reference for the development of in vitro diagnostic technologies for emerging infectious diseases and the science and technology decision making of the government.
|
|
Received: 27 September 2020
Published: 08 April 2021
|
|
|
|
Corresponding Authors:
Kai-yun MAO
E-mail: kymao@sibs.ac.cn
|
|
|
| [1] |
World Health Organization. WHO coronavirus disease (COVID-19). [2020-09-24].https://covid19.who.int/.
|
|
|
| [2] |
Mizumoto K, Kagaya K, Zarebski A, et al. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama,Japan, 2020. Euro Surveill, 2020,25(10): DOI: 10.2807/1560-7917.es.2020.25.10.2000180.
doi: 10.2807/1560-7917.ES.2020.25.10.2000180
pmid: 32183930
|
|
|
| [3] |
Sheridan C. Coronavirus and the race to distribute reliable diagnostics. Nature Biotechnology, 2020,38(4):382-384.
|
|
|
| [4] |
Wang W L, Xu Y L, Gao R Q, et al. Detection of SARS-CoV-2 in different types of clinical specimens. The Journal of the American Medical Association, 2020,323(18):1843-1844.
|
|
|
| [5] |
Wu J G, Liu J S, Li S J, et al. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients. Travel Medicine and Infectious Disease, 2020,37:101673.
pmid: 32311437
|
|
|
| [6] |
U.S. Food & Drug Administration. Accelerated emergency use authorization (EUA) summary SARS-CoV-2 ASSAY. [2020-9-24]. www.fda.gov/media/136875/download.
|
|
|
| [7] |
Carter L J, Garner L V, Smoot J W, et al. Assay techniques and test development for COVID-19 diagnosis. ACS Central Science, 2020,6(5):591-605.
pmid: 32382657
|
|
|
| [8] |
U.S. Food & Drug Administration.ePlex?SARS-CoV-2 test assay manual. [2020-9-24]. https://www.fda.gov/media/136282/download.
|
|
|
| [9] |
Cepheid. XpertfiXpress SARS-CoV-2. [2020-9-24]. https://www.cepheid.com/coronavirus.
|
|
|
| [10] |
马丽敏, 卢亦愚. 核酸等温扩增技术研究进展. 浙江预防医学, 2013,25(1):24-27.
|
|
|
| [10] |
Ma L M, Lu Y Y. Research progress in isothermal amplification of nucleic acids. Zhejiang Journal of Preventive Medicine, 2013,25(1):24-27.
|
|
|
| [11] |
Joung J, Ladha A, Saito M, et al. Point-of-care testing for COVID-19 using SHERLOCK diagnostics med Rxiv. 2020,5:20091231.
|
|
|
| [12] |
Smithgall M C, Scherberkova I, Whittier S, et al. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the rapid detection of SARS-CoV-2. Journal of Clinical Virology, 2020,128:104428.
doi: 10.1016/j.jcv.2020.104428
pmid: 32434706
|
|
|
| [13] |
高闪电, 常惠芸, 独军政, 等. 转录介导的扩增技术及其在诊断中的应用. 中国生物工程杂志, 2010,30(4):120-124.
|
|
|
| [13] |
Gao S D, Chang H Y, Du J Z, et al. Transcription mediated amplification and its applications in diagnosis. China Biotechnology, 2010,30(4):120-124.
|
|
|
| [14] |
East-Seletsky A, O’Connell M R, Knight S C , et al. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection. Nature, 2016,538(7624):270-273.
doi: 10.1038/nature19802
pmid: 27669025
|
|
|
| [15] |
Gootenberg J S, Abudayyeh O O, Lee J W, et al. Nucleic acid detection with CRISPR-Cas13a/C2c2 Science, 2017,356(6336):438-442.
doi: 10.1126/science.aam9321
pmid: 28408723
|
|
|
| [16] |
Joung J, Ladha A, Saito M, et al. Detection of SARS-CoV-2 with SHERLOCK one-pot testing. New England Journal of Medicine, 2020,383(15):1492-1494.
|
|
|
| [17] |
Chen J S, Ma E B, Harrington L B, et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science, 2018,360(6387):436-439.
pmid: 29449511
|
|
|
| [18] |
Shen M Z, Zhou Y, Ye J W, et al. Recent advances and perspectives of nucleic acid detection for coronavirus. Journal of Pharmaceutical Analysis, 2020,10(2):97-101.
doi: 10.1016/j.jpha.2020.02.010
pmid: 32292623
|
|
|
| [19] |
Tian B, Gao F, Fock J, et al. Homogeneous circle-to-circle amplification for real-time optomagnetic detection of SARS-CoV-2 RdRp coding sequence. Biosensors and Bioelectronics, 2020,165:112356.
doi: 10.1016/j.bios.2020.112356
pmid: 32510339
|
|
|
| [20] |
Guo X, Geng P, Wang Q, et al. Development of a single nucleotide polymorphism DNA microarray for the detection and genotyping of the SARS coronavirus. Journal of Microbiology and Biotechnology, 2014,24(10):1445-1454.
pmid: 24950883
|
|
|
| [21] |
Hedde P N, Abram T J, Jain A, et al. A modular microarray imaging system for highly specific COVID-19 antibody testing. Lab on a Chip, 2020,20(18):3302-3309.
doi: 10.1039/d0lc00547a
pmid: 32743622
|
|
|
| [22] |
陶悦, 傅启华, 莫茜. 病原宏基因组测序在新型冠状病毒检测中的应用与挑战. 中华检验医学杂志, 2020,43(3):217-220.
|
|
|
| [22] |
Tao Y, Fu Q H, Mo Q. Application and challenge of metagenome sequencing in detection of SARS-CoV-2. Chinese Journal of Laboratory Medicine, 2020,43(3):217-220.
|
|
|
| [23] |
Wang M, Fu A, Hu B S, et al. Nanopore targeted sequencing for the accurate and comprehensive detection of SARS‐CoV‐2 and other respiratory viruses. Small, 2020,16(32):e2002169.
doi: 10.1002/smll.202002169
pmid: 32578378
|
|
|
| [24] |
任志奇, 吴英松, 刘天才. 新型免疫层析技术的研究进展. 广东医学, 2013,34(2):312-314.
|
|
|
| [24] |
Ren Z Q, Wu Y S, Liu T C. Research progress of new immunochromatography technology. Guangdong Medical Journal, 2013,34(2):312-314.
|
|
|
| [25] |
万孚生物. 万孚生物:国内首个新冠病毒抗体检测试剂获证上市. [2020-02-24]. http://gdsta.cn/Item/30307.aspx.
|
|
|
| [25] |
Wondfo. China’s first SARS-CoV-2 antibody detection kit has been listed on the market. [2020-02-24]. http://gdsta.cn/Item/30307.aspx.
|
|
|
| [26] |
李晓非, 刘贵明, 李婉澜, 等. 化学发光法检测新型冠状病毒抗体在临床的应用价值. 山东大学学报(医学版), 2020,58(5):46-50.
|
|
|
| [26] |
Li X F, Liu G M, Li W L, et al. Application value of chemiluminescent immunoassay in the detection of 2019-nCoV antibodies. Journal of Shandong University (Health Sciences), 2020,58(5):46-50.
|
|
|
| [27] |
雍黎. 化学发光法新冠病毒抗体检测试剂盒上市. [2020-03-06]. http://digitalpaper.stdaily.com/http_www.kjrb.com/kjrb/html/2020-03/06/content_440863.htm?spm=C73544894212.P26359761204.0.0&div=-1.
|
|
|
| [27] |
Yong L. SARS-CoV-2 antibody detection kit based on chemiluminescence has been listed on the market. [2020-03-06]. http://digitalpaper.stdaily.com/http_www.kjrb.com/kjrb/html/2020-03/06/content_440863.htm?spm=C73544894212.P26359761204.0.0&div=-1.
|
|
|
| [28] |
Lawler R. Abbott’s 15-minute, $5 COVID-19 test gets FDA authorization. [2020-08-27]. https://www.msn.com/en-us/news/technology/abbott-s-15-minute-5-covid-19-test-gets-fda-authorization/ar-BB18pyx6.
|
|
|
| [29] |
Stanley S. PathSensors, Inc Announced the Development of a SARS-CoV-2 Biosensor. [2020-03-24]. https://pathsensors.com/psi-sars-cov-2-biosensor/.
|
|
|
| [30] |
Optics Org. CONVAT project aims for point-of-care Covid-19 diagnosis. [2020-04-08]. https://optics.org/news/11/4/13.
|
|
|
| [31] |
李庆梅, 张亮亮, 张洪, 等. 基于纳米技术的病原微生物核酸快速检测研究进展. 临床检验杂志, 2019,37(7):491-494.
|
|
|
| [31] |
Li Q M, Zhang L L, Zhang H, et al. Research progress of rapid detection of nucleic acid for pathogenic microorganism based on Nanotechnology. Chinese Journal of Clinical Laboratory Science, 2019,37(7):491-494.
|
|
|
| [32] |
Moitra P, Alafeef M, Dighe K, et al. Selective naked-eye detection of SARS-CoV-2 mediated by N gene targeted antisense oligonucleotide capped plasmonic nanoparticles. ACS Nano, 2020,14(6):7617-7627.
doi: 10.1021/acsnano.0c03822
pmid: 32437124
|
|
|
| [33] |
李纯, 庄颖娜. 中国军地联合研制新型纳米材料新冠病毒抗体检测试剂盒. [2020-07-07]. https://www.sohu.com/a/406193275_123753.
|
|
|
| [33] |
Li C, Zhuang Y N. Chinese military and local governments jointly develop a new nano material for SARS-CoV-2 antibody detection kit. [2020-07-07]. https://www.sohu.com/a/406193275_123753.
|
|
|
| [34] |
Zhu G K, Li J, Meng Z, et al. Learning from large-scale wearable device data for predicting the epidemics trend of COVID-19. Discrete Dynamics in Nature and Society, 2020,2020:1-8.
|
|
|
| [35] |
Hoilett O. Detect CoVID-19 symptoms using wearable device and Ai. [2020-07-11]. https://hackaday.com/2020/07/11/detect-covid-19-symptoms-using-wearable-device-and-ai/.
|
|
|
| [36] |
Eversden A. What does military AI need to detect COVID? Data from wearables. [2020-09-23]. https://www.c4isrnet.com/artificial-intelligence/2020/09/22/what-does-military-ai-need-to-detect-covid-data-from-wearables/.
|
|
|
| [37] |
Rossignol J. Apple watch powers three new health studies focused on asthma, heart failure, and early detection of COVID-19. [2020-09-15]. https://www.macrumors.com/2020/09/15/apple-watch-health-research-studies/.
|
|
|
| [38] |
World Health Organization. A coordinated global research roadmap:2019Novel Coronavirus. [2020-09-24]. https://www.who.int/blueprint/priority-diseases/key-action/Coronavirus_Roadmap_V9.pdf?ua=1.
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
